Immix Biopharma to Participate in the 45th Annual J.P. Morgan Healthcare Conference
LOS ANGELES, CA, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), a global leader in AL Amyloidosis, today announced that it will present at the 45th Annual J.P. Morgan Healthcare Conference being held January 11-14, 2027 in San Francisco, CA.
Covered in this story
Call it yourself
No calls on $IMMX yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Immix Biopharma →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.